Literature DB >> 17071178

The need for flexibility in the operative management of type III paraesophageal hernias.

Thomas R McLean1, Chris C Haller, Stephen Lowry.   

Abstract

BACKGROUND: A myriad of operation exist to treat type III paraesophageal hernias (T3PH). How does one choose?
METHODS: A retrospective review of a consecutive series of resident-preformed T3PH repair.
RESULTS: Three patients with T3PH were operated on during a 6-year period. The presentation of each patient was unique. Three different surgical procedures were used to treat these patients depending on the patient's condition at presentation, the location of the gastroesophageal junction, and the documentation of reflux. Transabdominal hernia reduction and a modified Hill procedure was used in 1 patient; a transthoracic hernia reduction was supplemented with a either a Belsy-Mark IV fundoplication or a Collis-Nissen gastroplasty in the other 2 patients. Patients were discharged home 7 (3-13) days postoperatively, and at a mean follow-up of 23 (2-60) months, all patients are asymptomatic and without radiographic recurrence.
CONCLUSION: Operative selection for T3PH should be flexible depending on the (1) urgency of symptoms, (2) location of the gastroesophageal junction, and (3) evidence for gastroesophageal reflux.

Entities:  

Mesh:

Year:  2006        PMID: 17071178     DOI: 10.1016/j.amjsurg.2006.08.030

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Transthoracic repair of paraesophageal diaphragmatic hernia presenting with symptoms mimicking cardiac disease (chest pain and breathlessness).

Authors:  Vikas Deep Goyal; Sanjeev Sharma; Som Mahajan; Ashwani Kumar
Journal:  J Clin Diagn Res       Date:  2014-10-20

2.  Emergency sleeve gastrectomy as rescue treatment for acute gastric necrosis due to type II paraesophageal hernia in an obese woman with gastric banding.

Authors:  Paolo Bernante; Cristiano Breda; Fabio Zangrandi; Fabio Pomerri; Maria Rosa Pelizzo; Mirto Foletto
Journal:  Obes Surg       Date:  2008-04-15       Impact factor: 4.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.